US business development firm Technology Vision Group has announced at the BioPartnering North America conference its collaboration with strategic partners to enable foreign lifescience companies to expand into China. This new initiative, BioPartnering China, aims to facilitate foreign life science companies to meet their Chinese counterparts in a professional and organized atmosphere. "TVG is creating an environment in which the world's best life science companies can meet their Chinese counterparts to do business together," the firm said. It will collaborate with the China National Center for Biotechnology Development in Beijing, a Department of the Ministry of Science and Technology, the Tianjin Municipal Science and Technology Commission (TSTC), the European Federation of Biotechnology and BayHelix Group, a Chinese life science business leaders' association. TVG will also work closely with ChinaBio which is based in Shanghai, San Diego and Palo Alto.
Robert Kilpatrick, a TVG partner, said, "BioPartnering China represents our long-term commitment to bring Chinese life science into the global supply chain." The BioPartnering China event will be held on June 26, in the Tianjin Special Economic Zone.
A further China networking forum, BioPartnering 2.0, will follow in London, UK, as part of BioPartnering Europe in October. BioPartnering 3.0 will be a full conference in China in 2010 and will comprise partnering, conference, networking and an exhibition.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze